The estimated Net Worth of Andrew A Krakauer is at least $1.12 Milion dollars as of 30 November 2021. Mr. Krakauer owns over 1,000 units of Teleflex stock worth over $864,169 and over the last 7 years he sold TFX stock worth over $0. In addition, he makes $254,480 as Independent Director at Teleflex.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Krakauer TFX stock SEC Form 4 insiders trading
Andrew has made over 2 trades of the Teleflex stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of TFX stock worth $307,230 on 30 November 2021.
The largest trade he's ever made was buying 1,000 units of Teleflex stock on 30 November 2021 worth over $307,230. On average, Andrew trades about 200 units every 121 days since 2018. As of 30 November 2021 he still owns at least 3,534 units of Teleflex stock.
You can see the complete history of Mr. Krakauer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Andrew Krakauer biography
Andrew A. Krakauer serves as Independent Director of the Company. Prior to his retirement in October 2016, Mr. Krakauer was Chief Executive Officer of Cantel Medical Corp. (“Cantel”), a provider of infection control products and services. During his 12 years at Cantel, Mr. Krakauer served in various executive and senior level positions, including Chief Executive Officer from November 2014 to July 2016; President and Chief Executive Officer from March 2009 to November 2014; President from April 2008 to March 2009; and Executive Vice President and Chief Operating Officer from August 2004 through April 2008. Mr. Krakauer also served as a member of Cantel’s board of directors from 2009 to 2016. Prior to joining Cantel, Mr. Krakauer was President of the Ohmeda Medical Division of Instrumentarium Corp. (which was acquired by General Electric Company in 2003), a provider of medical devices, from 1998 to 2004.
What is the salary of Andrew Krakauer?
As the Independent Director of Teleflex, the total compensation of Andrew Krakauer at Teleflex is $254,480. There are 13 executives at Teleflex getting paid more, with Liam Kelly having the highest compensation of $6,782,760.
How old is Andrew Krakauer?
Andrew Krakauer is 65, he's been the Independent Director of Teleflex since 2018. There are 3 older and 14 younger executives at Teleflex. The oldest executive at Teleflex Incorporated is George Babich, 68, who is the Lead Independent Director.
What's Andrew Krakauer's mailing address?
Andrew's mailing address filed with the SEC is C/O 550 E. SWEDESFORD ROAD, SUITE 400, WAYNE, PA, 19087.
Insiders trading at Teleflex
Over the last 21 years, insiders at Teleflex have traded over $16,880,558 worth of Teleflex stock and bought 4,250 units worth $1,104,860 . The most active insiders traders include Gretchen R Haggerty, W Kim Foster a Benson Smith. On average, Teleflex executives and independent directors trade stock every 22 days with the average trade being worth of $1,065,906. The most recent stock trade was executed by Stuart A Randle on 16 August 2024, trading 2,674 units of TFX stock currently worth $323,554.
What does Teleflex do?
teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. headquartered in wayne, pa, teleflex employs approximately 12,000 people worldwide and serves healthcare providers in more than 150 countries.
What does Teleflex's logo look like?
Complete history of Mr. Krakauer stock trades at Teleflex
Teleflex executives and stock owners
Teleflex executives and other stock owners filed with the SEC include:
-
Liam Kelly,
Chairman of the Board, President, Chief Executive Officer -
Thomas Powell,
Chief Financial Officer, Executive Vice President -
Liam J. Kelly,
Chairman, Pres & CEO -
James Leyden,
Corporate Vice President, General Counsel, Secretary -
Cameron Hicks,
Corporate Vice President - Human Resources and Communications -
Thomas E. Powell,
Exec. VP & CFO -
Karen Boylan,
Vice President - Global Strategic Projects -
James P. Winters,
Corp. VP, Manufacturing and Supply Chain -
Cameron P. Hicks,
Corp. VP & Chief HR Officer -
John Heinmiller,
Independent Director -
George Babich,
Lead Independent Director -
Candace Duncan,
Independent Director -
Stuart Randle,
Independent Director -
Andrew Krakauer,
Independent Director -
Gretchen Haggerty,
Independent Director -
Stephen Klasko,
Independent Director -
Richard Packer,
Independent Director -
James Winters,
Corporate Vice President - Manufacturing and Supply Chain -
Mario Wijker,
Corporate Vice President - QA/RA -
Jake Elguicze,
Treasurer and Vice President Investor Relations -
James Ferguson,
Pres & GM of Surgical -
Howard Cyr,
Corp. VP & Chief Compliance Officer -
Daniel V. Logue,
Corp. VP, Gen. Counsel & Sec. -
John Hsu C.F.A.,
VP of Investor Relations -
Timothy F. Duffy,
VP & Chief Information Officer -
John R. Deren,
Corp. VP & Chief Accounting Officer -
W Kim Foster,
Director -
Thomas Anthony Kennedy,
Senior VP, Global Operations -
Patricia C Barron,
Director -
Jeffrey A Graves,
Director -
William Roland Cook,
Director -
Benson Smith,
Director -
Richard A Meier,
Exec. Vice Pres. and CFO -
James W Zug,
Director -
Charles Edward Williams,
Corp. Controller and CAO -
John B Suddarth,
President-Aerospace -
Jeffrey P Black,
President, CEO -
Vincent Northfield,
President - Commercial -
R Ernest Waaser,
President - Medical -
Harold L Iii Yoh,
Director -
Sigismundus W W Lubsen,
Director -
Seldeneck Judith M Von,
Director -
Matthew J Jennings,
Sr. VP, Corp. Development -
Kevin K Gordon,
Vice Pres. Corporate -
Julie Mcdowell,
Sr. VP Corp. Communic. -
John J Sickler,
Vice Chairman -
Randall P Gaboriault,
Sr. Vice Pres. & Chf Info Off -
Laurence G Miller,
Sr.VP, General -
Forrest R Whittaker,
President - Medical -
James W Eug,
Director -
Steven Kent Chance,
Vice Pres., General -
James W Stratton,
Director -
Clark D Handy,
Exec.Vice Pres. -
Martin S Headley,
Exec. Vice Pres. -
Lennox K Black,
Non-Executive -
James V Agnello,
Corporate Controller -
Donald Beckman,
Director -
Joan W Schwartz,
Assoc.Gen'l Counsel -
Thomas M Byrne,
Assistant Treasurer -
Joseph S Gonnella,
Director -
C Jeffrey Jacobs,
Treasurer -
Harold L Jr Zuber,
Exec. Vice Pres. and -
Janine Dusossoit,
-
Jaewon Ryu,
Director -
Jay White,
CVP & Pres, Global Commercial -
John Deren,
Corp. VP & CAO -
Daniel V. Logue,
CVP, General Counsel & Secty -
Neena M Patil,
Director